Growth factor-induced actin reorganization in Swiss 3T3 cells.
D016475:3T3 Cells; D000199:Actins / Q000187:drug effects / Q000648:ultrastructure*; D000818:Animals; D000077214:Becaplermin; D001839:Bombesin / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D002417:Cattle; D004815:Epidermal Growth Factor / Q000494:pharmacology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D005353:Fibronectins / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins / Q000494:pharmacology; D013552:Swine; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D019096:Vitronectin / Q000494:pharmacology
D000199:Actins; D005353:Fibronectins; D006133:Growth Substances; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D019096:Vitronectin; D016222:Fibroblast Growth Factor 2; D000077214:Becaplermin; D004815:Epidermal Growth Factor; D013755:Tetradecanoylphorbol Acetate; D001839:Bombesin; D001920:Bradykinin